Wei Yingfang, Wang Huadong, Guo Shanshan, Yan Jie, Long Fei
Key Laboratory of Standardization of Chinese Crude Drug of Ministry of Education, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Zhongguo Zhong Yao Za Zhi. 2010 Jul;35(13):1773-6.
To determine the medicinal part and varieties of Cannabis Sativa through herbal textual research to Provide bibliographic reference for clinical application.
Herbal textual research of C. Sativa from ancient herbal works and modern data analysis.
Through the herbal textual research, the plant of the C. sativa, for Fructus Cannabis used now is identical with that described in ancient herbal literatures. People did not make a sharp distinction on medicinal part of C. sativa in the early stage literatures, female inflorescence and unripe fruit, fruit and kernel of seed were all used. Since Taohongjing realized the toxicity ofpericarp, all the herbal and prescription works indicate that the pericarp shall be removed before usage and only the kernel can be used. However, in modem literatures, both fruit and kernel can be used as medicinal part.
The plants for Fructus Cannabis described in modern and ancient literatures are identical. The base of the original plant is the same either in ancient or modern. And the toxicity of the fruit is more than that of the kernel. The kernel is the exact medicinal part of C. Sativa.
通过本草考证确定火麻仁的药用部位及品种，为临床应用提供文献依据。
对历代本草中火麻仁相关内容进行本草考证，并结合现代资料进行分析。
经本草考证，现今药用的火麻仁原植物与古代本草记载一致。早期文献对火麻仁药用部位区分不严格，雌花序、未成熟果实、果实及种仁均入药。自陶弘景认识到果皮有毒后，历代本草及方剂著作均指出入药前应去果皮，仅用种仁。然而，现代文献中果实和种仁均可作为药用部位。
古今文献记载的火麻仁原植物相同，原植物基源古今一致。果实毒性大于种仁，种仁是火麻仁的准确药用部位。
